All Therapeutic Areas
🎗️
Oncology
255 drugs in pipeline from 10 companies
255
Drugs in Pipeline
10
Companies
10
Upcoming Catalysts
255
Phase 3 Trials
Upcoming Catalysts
Jul '26
Jul '26
JNGHFPhase 3
TACE+Camrelizumab+Apatinib mesylate Phase 3 Est. Readout
TACE+Camrelizumab+Apatinib mesylate423
Jul '26
2d
days
Jul '26
Pipeline by Phase
Phase 3
255
Active Companies
AZN
11 drugsAstraZeneca PLC
MRK
20 drugsMERCK
IOBTQ
1 drugsIO Biotech, Inc.
GILD
2 drugsGilead Sciences, Inc.
PFE
12 drugsPFIZER
SKBBY
6 drugsSichuan Kelun-Biotech Biopharmaceutical Co., Ltd./ADR
ORIC
1 drugsOric Pharmaceuticals, Inc.
AZNCF
17 drugsASTRAZENECA PLC
JAZZ
1 drugsJazz Pharmaceuticals plc
PHM.MC
13 drugsPharmaMar, S.A.
Related Conditions
cancertumorcarcinomalymphomaleukemiamelanomaoncologysarcomamyelomametastaticneoplasmmalignantbreast cancerlung cancerprostate cancercolorectalpancreaticglioblastomahepatocellularrenal cellovarianbladdernsclcsclcamlcllalldlbclhodgkinnon-hodgkin
